Literature DB >> 36108311

Light-Sheet Microscopy of the Optic Nerve Reveals Axonal Degeneration and Microglial Activation in NMDA-Induced Retinal Injury.

Yonju Ha1, Lorenzo F Ochoa2, Olivia Solomon2,3, Shuizhen Shi1, Paula P Villarreal2, Shengguo Li1, Seth Buscho1, Gracie Vargas2, Wenbo Zhang1,2.   

Abstract

Purpose: Optic nerve degeneration is a feature of neurodegenerative eye diseases and causes irreversible vision loss. Therefore, understanding the degenerating patterns of the optic nerve is critical to find the potential therapeutic target for optic neuropathy. However, the traditional method of optic nerve degeneration has the limitations of losing spatiotemporal tissue information. Light sheet fluorescence microscopy (LSFM) is a fluorescence microscopy technique that allows capturing 3D images rapidly with a high spatial optical resolution. In this study, we evaluated the availability of LSFM on the optic nerve with NMDA injected Thy1-CFP mice.
Methods: NMDA injected to both eyes of Thy1-CFP mice. After 7 days from the injection, the retina and optic nerve were collected and immunostained with anti-Iba1 antibody. NMDA excitotoxicity induced RGC, and its axon loss and microglial activation in the retina were observed using confocal microscopy. The immunostained optic nerve was completed the optical clearing process with TDE and mounted for LSFM imaging.
Results: We found that retinal flatmounts confirmed significant loss of CFP-expressing RGC and axon degradation and loss in Thy1-CFP mice at 7 days after NMDA injection. Together with these data verifying that NMDA induces RGC and its axon loss, we confirmed that NMDA excitotoxicity induced microglia activation and leukostasis, such as increased microglia number, transform its morphology to ameboid or round, and increase in attached leukocytes in vessels. Using LSFM, we observed that CFP expressing nerve fiber was well organized and arranged parallel in vehicle treated optic nerve, whileas NMDA injected optic nerve showed axon swelling and fragmentation and loss of axon density from the anterior to the posterior regions. Furthermore, LSFM enabled the observation of microglia phenotype transformation in the entire optic nerve. Unlike microglia in vehicle injected optic nerve, microglia in NMDA injected optic nerve displayed larger soma and short process with high Iba1 expression through the entire optic nerve from the anterior to posterior. Conclusions: In summary, we examined the applicability of the modified optic clearing protocol for the optic nerve and verified it enabled to acquiring of the 3D images of the optic nerve successfully revealing the complex spatial relationships between the axons, microglia and vasculature throughout the entire organ with single acquisitions. With these optimized techniques, we successfully obtained the high-resolution 3D images of NMDA-induced optic neuropathy, including the clues for optic nerve degeneration such as axon swelling, axonal fragmentation, and microglia activation. Overall, we believe that our current study could help understand the pathology of the optic nerve in neurodegenerative diseases, and it will be the basis for translational research.

Entities:  

Keywords:  Light sheet microscopy (LSM); Microglia; Mouse; NMDA; Optic nerve; RGC; Retina

Year:  2021        PMID: 36108311      PMCID: PMC9450914     

Source DB:  PubMed          Journal:  EC Ophthalmol


  41 in total

1.  SeeDB: a simple and morphology-preserving optical clearing agent for neuronal circuit reconstruction.

Authors:  Meng-Tsen Ke; Satoshi Fujimoto; Takeshi Imai
Journal:  Nat Neurosci       Date:  2013-06-23       Impact factor: 24.884

2.  Light-sheet fluorescence microscopy for quantitative biology.

Authors:  Ernst H K Stelzer
Journal:  Nat Methods       Date:  2015-01       Impact factor: 28.547

3.  Three-dimensional imaging of solvent-cleared organs using 3DISCO.

Authors:  Ali Ertürk; Klaus Becker; Nina Jährling; Christoph P Mauch; Caroline D Hojer; Jackson G Egen; Farida Hellal; Frank Bradke; Morgan Sheng; Hans-Ulrich Dodt
Journal:  Nat Protoc       Date:  2012-10-11       Impact factor: 13.491

4.  ClearT: a detergent- and solvent-free clearing method for neuronal and non-neuronal tissue.

Authors:  Takaaki Kuwajima; Austen A Sitko; Punita Bhansali; Chris Jurgens; William Guido; Carol Mason
Journal:  Development       Date:  2013-03       Impact factor: 6.868

Review 5.  Diabetic papillopathy: current and new treatment options.

Authors:  Gian P Giuliari; Ama Sadaka; Peter Y Chang; Rafael T Cortez
Journal:  Curr Diabetes Rev       Date:  2011-05

Review 6.  Role of Glutamate and NMDA Receptors in Alzheimer's Disease.

Authors:  Rui Wang; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Exploration of the glutamate-mediated retinal excitotoxic damage: a rat model of retinal neurodegeneration.

Authors:  Ling Gao; Qi-Jun Zheng; Li-Qian-Yu Ai; Kai-Jian Chen; Yuan-Guo Zhou; Jian Ye; Wei Liu
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

8.  Imaging mouse retinal ganglion cells and their loss in vivo by a fundus camera in the normal and ischemia-reperfusion model.

Authors:  Hiroshi Murata; Makoto Aihara; Yi-Ning Chen; Takashi Ota; Jiro Numaga; Makoto Araie
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-08       Impact factor: 4.799

9.  Optical coherence tomography findings in Huntington's disease: a potential biomarker of disease progression.

Authors:  Hannah M Kersten; Helen V Danesh-Meyer; Dean H Kilfoyle; Richard H Roxburgh
Journal:  J Neurol       Date:  2015-08-02       Impact factor: 4.849

10.  Mouse retinal cell behaviour in space and time using light sheet fluorescence microscopy.

Authors:  Claudia Prahst; Parham Ashrafzadeh; Thomas Mead; Ana Figueiredo; Karen Chang; Douglas Richardson; Lakshmi Venkaraman; Mark Richards; Ana Martins Russo; Kyle Harrington; Marie Ouarné; Andreia Pena; Dong Feng Chen; Lena Claesson-Welsh; Kin-Sang Cho; Claudio A Franco; Katie Bentley
Journal:  Elife       Date:  2020-02-19       Impact factor: 8.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.